Marex was highlighted in a Q2 2025 investor letter, discussing the impact of Trump-era tariffs and onshoring trends.
1 report, 0 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Marex was highlighted in a Q2 2025 investor letter, discussing the impact of Trump-era tariffs and onshoring trends.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Marex
company in Fevik, Norway
Nothing else this week.
Related events
- The new event concerns the impact of Trump-era tariffs and onshoring trends on Viatris.
- Trump's tariffs spooked markets, specifically impacting MSCI.
- Goldman Sachs and Zeta Interactive noted that tariffs and onshoring benefit AI stocks, citing accelerated Q2 growth and raising price targets.
- Elastic benefits from the trend of onshoring and tariffs associated with the Trump administration.
- Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
Coverage
Newest first; wire copies grouped- Unknown outlet